Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03219522
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
| Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
|---|---|---|---|---|---|
| Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
IFL | (3S,4R,5R)-3,4-DIHYDROXY-5-(HYDROXYMETHYL)PIPERIDIN- 2-ONE | A,B | 1UZ1 | 0.72 |  |
| IFL | (3S,4R,5R)-3,4-DIHYDROXY-5-(HYDROXYMETHYL)PIPERIDIN- 2-ONE | A | 2V38 | 0.72 | |
| IFL | (3S,4R,5R)-3,4-DIHYDROXY-5-(HYDROXYMETHYL)PIPERIDIN- 2-ONE | A,B | 2VJX | 0.72 | |
| IFL | (3S,4R,5R)-3,4-DIHYDROXY-5-(HYDROXYMETHYL)PIPERIDIN- 2-ONE | A | 1UZ4 | 0.72 | |
GDL | 2-ACETAMIDO-2-DEOXY-D-GLUCONO-1,5- LACTONE | A,B | 1UR9 | 0.77 | |
| GDL | 2-ACETAMIDO-2-DEOXY-D-GLUCONO-1,5- LACTONE | A,B,C,D,E,F | 1O7A | 0.77 | |
| GDL | 2-ACETAMIDO-2-DEOXY-D-GLUCONO-1,5- LACTONE | A,B | 1UR8 | 0.77 | |
F34 | N-[(3S,4R,5R,6R)-4,5,6-trihydroxyazepan- 3-yl]acetamide | A,B | 2W67 | 0.7 | |
097 | (2S,3R)-N~4~-[(1S)-2,2-dimethyl- 1-(methylcarbamoyl)propyl]-N~1~,2- dihydroxy-3-(2-methylpropyl)butanediamide | A,B | 3HY7 | 0.7 | |
| 097 | (2S,3R)-N~4~-[(1S)-2,2-dimethyl- 1-(methylcarbamoyl)propyl]-N~1~,2- dihydroxy-3-(2-methylpropyl)butanediamide | A,B | 2JIH | 0.7 | |
| 097 | (2S,3R)-N~4~-[(1S)-2,2-dimethyl- 1-(methylcarbamoyl)propyl]-N~1~,2- dihydroxy-3-(2-methylpropyl)butanediamide | A | 1R55 | 0.7 | |
SCV | N6-[(1S)-2-{[(1R)-1-CARBOXY-2-METHYLPROPYL]OXY}- 1-(MERCAPTOCARBONYL)-2-OXOETHYL]- 6-OXO-L-LYSINE | A | 1HB2 | 0.71 | |
| SCV | N6-[(1S)-2-{[(1R)-1-CARBOXY-2-METHYLPROPYL]OXY}- 1-(MERCAPTOCARBONYL)-2-OXOETHYL]- 6-OXO-L-LYSINE | A | 1HB4 | 0.71 | |
| SCV | N6-[(1S)-2-{[(1R)-1-CARBOXY-2-METHYLPROPYL]OXY}- 1-(MERCAPTOCARBONYL)-2-OXOETHYL]- 6-OXO-L-LYSINE | A | 1HB3 | 0.71 | |
PT3 | N-PROPYL-TARTRAMIC ACID | A,B,C,D | 2HPA | 0.72 | |
NAY | 6,7,8,9-TETRAHYDROXY-5-METHYLCARBOXAMIDO- 2-OXONONANOIC ACID | A,C | 1F74 | 0.74 | |
C6L | N-hexanoyl-L-homoserine | A | 3DHA | 0.72 | |
| C6L | N-hexanoyl-L-homoserine | A | 3DHB | 0.72 | |
E6C | N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- 2-METHYL-BUTANE | A | 1PPP | 0.73 | |
| E6C | N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- 2-METHYL-BUTANE | A | 1PE6 | 0.73 | |
| E6C | N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- 2-METHYL-BUTANE | A | 1ITO | 0.73 | |
HMN | 2,4,6,7,8,9-HEXAHYDROXY-5-METHYLCARBOXAMIDO NONANOIC ACID | A,B,C,D | 1F73 | 0.73 | |
NAU | 4,4,6,7,8,9-HEXAHYDROXY-5-METHYLCARBOXAMIDONONANOIC ACID | A,C | 1F7B | 0.71 | |
NAV | 6,7,8,9-TETRAHYDROXY-5-METHYLCARBOXAMIDO- 4-OXONONANOIC ACID | A,C | 1F7B | 0.77 | |
SUJ | (2R,3R)-2-[(3S,6R)-3-AMINO-6-HYDROXY- 2-OXOPIPERIDINYL]-3-HYDROXYBUTANOIC ACID | C,D | 1OKX | 0.72 | |
PCV | 5-AMINO-3-HYDROXY-2-(2-OXO-AZETIDIN- 1-YL)-PENTANOIC ACID | A | 1DRT | 0.72 | |